Chemoinformaics analysis of Labd-7,13-dien-15-ol
| Molecular Weight | 290.491 | nRot | 4 |
| Heavy Atom Molecular Weight | 256.219 | nRig | 12 |
| Exact Molecular Weight | 290.261 | nRing | 2 |
| Solubility: LogS | -5.217 | nHRing | 0 |
| Solubility: LogP | 5.624 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 56.873 |
| nHD | 1 | BPOL | 34.109 |
| QED | 0.677 |
| Synth | 3.973 |
| Natural Product Likeliness | 3.337 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.066 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.4 |
| MDCK | 0.0000142 |
| BBB | 0.874 |
| PPB | 0.966237 |
| VDSS | 2.7 |
| FU | 0.0261087 |
| CYP1A2-inh | 0.199 |
| CYP1A2-sub | 0.361 |
| CYP2c19-inh | 0.25 |
| CYP2c19-sub | 0.834 |
| CYP2c9-inh | 0.369 |
| CYP2c9-sub | 0.802 |
| CYP2d6-inh | 0.039 |
| CYP2d6-sub | 0.62 |
| CYP3a4-inh | 0.421 |
| CYP3a4-sub | 0.252 |
| CL | 9.754 |
| T12 | 0.101 |
| hERG | 0.011 |
| Ames | 0.002 |
| ROA | 0.025 |
| SkinSen | 0.838 |
| Carcinogencity | 0.033 |
| EI | 0.651 |
| Respiratory | 0.675 |
| NR-Aromatase | 0.031 |
| Antiviral | No |
| Prediction | 0.763326 |